FITC/ PE - anti Human HLA-DR/CD8 - GRB-1; 33-2A3

FITC/ PE - anti Human HLA-DR/CD8 - GRB-1; 33-2A3

Catalog Number:
A001108922IMM
Mfr. No.:
HLADRF8PE1-50T
Price:
$511
  • Size:
    50 test
    Quantity:
    Add to Cart:
      • Overview
        • The HLA-DR/CD8 is used for indentification of T lymphocytes CD8+/HLA-DR+. Elevated levels of CD8+/HLA-DR+ T lymphocytes are observed in human immunodeficiency virus (HIV) infection and during the acute stages of Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection. In HIV infection, the coexpression of CD8 andCD38, with a concomitant low percentage of CD4+ lymphocytes, is closely associated with disease progression. Selective elevation of HLA-DR+/CD38-/CD8+ cells may be a marker of stable HIV disease.

          Please contact us at for specific academic pricing.

      • Properties
        • Reactivity
          human
          Clone
          GRB-1; 33-2A3
          Conjugate
          FITC; PE
          Regulatory Status
          RUO

          * For research use only.

      • Applications
        • Application
          Flow Cytometry

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.